TOBR2 TOBRAMYCIN 04491033190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-04-14 for TOBR2 TOBRAMYCIN 04491033190 manufactured by Roche Diagnostics.

Event Text Entries

[72887977] This event occurred in (b)(6). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[72887978] The customer has tested 1 patient with tobr2 tobramycin (tobr2) on a cobas 6000 series system, tobr tobramycin (tobr) on a cobas integra system and the abbott tobramycin assay on an architect system. The customer provided results from the patient obtained between (b)(6) 2015 and (b)(6) 2017. The customer is questioning the tobr2 results from the cobas 6000 series system because they are consistently higher even after stopping tobramycin treatment and without the patient showing any symptoms of toxicity. The customer thinks the tobr results from the integra system are correct. Based on the data provided, comparison results on (b)(6) 2015 between the tobr2 assay on the cobas 6000 system and the tobr assay on the cobas integra system were erroneous. Refer to attached data for a chronological list of the patient test results, specific treatment received and patient weight at time of test if available. There was no allegation that an adverse event occurred. The customer believes there is an interferent in the patient sample affecting the results. The customer performed a series of investigations in an attempt to identify the interference. Refer to the attached data for the details of the customer? S investigation. All the samples from the patient were taken at trough level. Some patient results were from finger stick tests and some patient results were from venous samples. It is not clear which results are from venous samples and which results are from finger sticks. Peak level samples are not monitored by the customer. The customer declines to provide calibration or quality control (qc) data as they don? T believe this is a method quality issue. A specific root cause could not be identified. Additional information was requested for investigation but was not provided. Two assays, the tobr2 with c6000 system and the tobramycin assay with the architect system are competitive immunoassay methods; one utilizing a polyclonal, and the other a monoclonal capture antibody, respectively. Only the competitive tobr assay with the integra system employing a monoclonal ab, seemed to produce the negative results expected for this patient. Since qc has been acceptable, analytical and pre-analytical quality issues have been excluded. The investigation stated an unknown substance is interfering with the tobr2 assay, however, since the patient sample is not available, this cannot be confirmed.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2017-00787
MDR Report Key6494067
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-04-14
Date of Report2017-04-14
Date of Event2015-12-02
Date Mfgr Received2017-03-06
Date Added to Maude2017-04-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameTOBR2 TOBRAMYCIN
Generic NameTOBRAMYCIN TEST SYSTEM
Product CodeKLB
Date Received2017-04-14
Model NumberNA
Catalog Number04491033190
Lot NumberASKU
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-04-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.